Company news

Immuron Limited news in 2016

Immuron Limited's news releases, calls and decks from 2016, newest first.

View company

Immuron Receives $1.6M R&D Tax Concession Refund

November 28, 2016

Immurons NASH Phase II Trial Achieves 100 Patient Milestone

October 28, 2016

NASH Phase II Trial reaches 75% of Patient Recruitment

October 10, 2016

Immurons $6M Rights Issue Closes Oversubscribed

October 4, 2016

Appendix 4E and Annual Report

August 30, 2016

Immuron Expands Collaborate with US Navy

August 29, 2016

US NIH to Fund Second IMC Fatty Liver Study - Pediatric NASH

August 18, 2016

Travelan to be Stocked by US Distributor Medique Products

August 8, 2016

Immuron to Cooperate with Universities on Autism Research

July 19, 2016

Immuron to repay outstanding Convertible Note in cash

July 17, 2016

IMC Signs Shigella Vaccine Developmt Agreement with US Army

June 20, 2016

Travelan and Protectyn Are Now Available For Sale in China

June 16, 2016

Travelan to Reach Upto 1.5M New US Customers via Magellans

June 14, 2016

Immuron Rights Issue Offer Booklet (May 2016)

May 31, 2016

Immuron Announces $6M Rights Issue Offer

May 30, 2016

NASH Phase II Trial Reaches 50% Recruitment Milestone

May 25, 2016

Immuron Announces E-Commerce Agreement with QBID in China

May 8, 2016

US Distribution Reach Expanded through McKesson

April 27, 2016

US Travelan Sales Network Widened by Allocation Inc Ptnrship

April 18, 2016

Expansion of US Travelan Sales Following CVS Pharmacy Launch

April 14, 2016

Immuron Improves Hadasit Royalty Terms

March 30, 2016

Appendix 4D - Half Yearly Report and Accounts

February 25, 2016

Immuron Initiates Pre-Clinical Colitis Development Program

February 21, 2016

Immuron Secures upto $1.7M Equity & Convertible Note Funding

February 17, 2016

Immuron Receives $1.47M R&D Tax Concession Refund

February 11, 2016

Analyst Reports on Immuron IMM-529 C. difficile Program

February 10, 2016

Decks in 2016